Gian Life Care Ltd (BSE: 542918) is a Kanpur, Uttar Pradesh-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹4 Cr, it ranks #5,018 by market cap among the 6,197 Indian listed companies on FinBizNet, and #16 of 18 in Medical Diagnostic Centres. At ₹4.29 (as of 16 Nov 2026), the share price is 66.9% below its 52-week high of ₹12.98 and 9.2% above its 52-week low of ₹3.93. The share price is down 64.5% over one year and down 13.2% over three months.
| Current Price | ₹4.29 |
|---|---|
| Market Cap | ₹4 Cr |
| BSE Code | 542918 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -0.19% |
| Return on Assets | 0.52% |
| 52-Week Range | ₹3.93 – ₹12.98 |
| 1-Year Price Change | -64.5% |
| 3-Month Price Change | -13.2% |
| Beta (1Y) | 0.23 |
| Headquarters | Kanpur, Uttar Pradesh |
| Website | gianlifecare.org |
| Revenue | ₹1 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 10.7% |
| EPS (Basic) | ₹0.12 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Gian Life Care Ltd reported revenue of ₹1 Cr in Q3 FY26, down 29.6% from ₹2 Cr in Q3 FY25 and up 69.7% from ₹1 Cr in Q2 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q3 FY25 (down 69.2%). Across the 5 quarters from Q3 FY25 to Q3 FY26, quarterly revenue ranged from ₹1 Cr (Q2 FY26) to ₹2 Cr (Q3 FY25). The company reported a net loss in 2 of these 5 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q3 FY26 | ₹1 Cr | ₹0 Cr | 10.7% |
| Q2 FY26 | ₹1 Cr | −₹0 Cr | −69.7% |
| Q1 FY26 | ₹1 Cr | ₹0 Cr | 5.7% |
| Q4 FY25 | ₹1 Cr | −₹0 Cr | −43.2% |
| Q3 FY25 | ₹2 Cr | ₹0 Cr | 24.5% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.
1. Medical Labs & Research-This segment provides diagnostic and related healthcare tests and services.
1. Laboratories Pathological Investigations-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Gian Life Care Ltd | ₹4 Cr | n/m | -0.19% | ₹1 Cr | -64.5% |
Listed by market capitalisation. Ratios are shown for context only.
Gian Life Care Ltd is trading at ₹4.29, with a market capitalisation of ₹4 Cr.
Gian Life Care Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Gian Life Care Ltd has a return on equity of -0.19%.
Gian Life Care Ltd is listed on the BSE under the scrip code 542918.
Gian Life Care Ltd's share price is down 64.5% over one year and down 13.2% over three months. Its 52-week range is ₹3.93 to ₹12.98.
In Q3 FY26, Gian Life Care Ltd reported revenue of ₹1 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.12 (standalone, parsed from the company's exchange filing).
Gian Life Care Ltd reported revenue of ₹1 Cr in Q3 FY26, down 29.6% from ₹2 Cr in Q3 FY25 and up 69.7% from ₹1 Cr in Q2 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.